Trials / Completed
CompletedNCT03324139
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.
Treatment of Intrauterine Growth Restriction With Low Molecular Heparin: Randomized Clinical Trial. Tratamiento Del Crecimiento Intrauterino Restringido Precoz Con Heparina de Bajo Peso Molecular: Ensayo clínico Aleatorizado.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Fundació Sant Joan de Déu · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN.
Detailed description
TREATMENT OF INTRAUTERINE GROWTH RESTRICTION WITH LOW MOLECULAR WEIGHT HEPARIN: RANDOMIZED CLINICAL TRIAL (TRACIP STUDY).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Low molecular weight heparin | Patients included in this study group will receive 3,500 IU / 0.2 ml / day of Bemiparina sc, from inclusion to delivery (estimated median of 5-6 weeks, with a maximum of 13 weeks). |
| DRUG | Placebos | Patients included in this study group will placebo (same presentation as the active drug), from inclusion to delivery (estimated median of 5-6 weeks, with a maximum of 13 weeks). |
Timeline
- Start date
- 2018-01-25
- Primary completion
- 2022-04-30
- Completion
- 2023-02-19
- First posted
- 2017-10-27
- Last updated
- 2024-04-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03324139. Inclusion in this directory is not an endorsement.